Roche pays $2.4 billion for rest of cancer expert Foundation Medicine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- Wall Street ends down as oil prices, Treasury yields rise
- Anthropic's Claude AI identifies novel enzyme system in DNA search
- AppLovin (APP) on watch amid 3% drop premarket as boutique comments circulate
- Plug Power COO resigns to join another company
- Xtend AI Robotics wins Phase III of USSOCOM lethal drone program
William Blair Downgrades Foundation Medicine (FMI) to Market Perform Following Takeover
June 19, 2018 12:48 PM EDTWilliam Blair downgraded Foundation Medicine (NASDAQ: FMI) from Outperform to Market Perform after the company agreed to be acquired by Roche.
For an analyst ratings summary and ratings history on Foundation Medicine click here. For more ratings news on Foundation Medicine click here.
Shares of Foundation Medicine closed at $106.45 yesterday.
... More